Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
基本信息
- 批准号:9275679
- 负责人:
- 金额:$ 80.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcylationBindingBinding ProteinsBiochemicalBiologyBone DiseasesCharacteristicsChemicalsComplexCongenital AbnormalityDefectDiabetes MellitusDimerizationDiseaseFamilyGoalsGrowth FactorHumanKnowledgeLigandsMalignant NeoplasmsMethodsMolecular ConformationMutateNeurodevelopmental DisorderPhosphotransferasesPlayReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingRecruitment ActivityResearchResearch Project SummariesResolutionRoleSignal TransductionSignaling MoleculeSpecificityTestingTherapeuticTyrosineWNT Signaling PathwayWnt proteinsWound Healingdimerhuman diseasein vivoinsightmembernovel therapeutic interventionnovel therapeuticsreceptorreceptor bindingtherapeutic target
项目摘要
Project Summary
The research proposed in this MIRA application seeks to understand unexplored mechanisms of
transmembrane signaling across the receptor tyrosine kinase (RTK) superfamily, members of which play an
important role in human disease – from neurodevelopmental disorders, to bone diseases, cancers, diabetes,
and several congenital malformations. In the traditional view of RTK signaling, growth factor ligands induce
receptor dimers that become tyrosine autophosphorylated and recruit downstream signaling molecules. As we
understand more about the 20 different RTK families (which include 58 RTKs), however, it becomes clearer
that this view only applies to a subset of these receptors. The research proposed here focuses on two
characteristics that demand a very different mechanistic view – RTKs that bind Wnt proteins (and do not
dimerize as a result) and RTKs that have `dead' kinase or pseudokinases in their intracellular regions. New
paradigms must be understood in order to appreciate how these important receptors signal. Our goals over
the next 5-10 years are: 1. To develop a coherent picture of the role played by RTKs in Wnt signaling (which
involves 4 of the 20 RTK families), 2. To understand how RTKs with pseudokinase domains that do not even
bind ATP (found in 5 of the 20 RTK families) can signal, and 3. To determine why pseudokinases are over-
represented among the Wnt-regulated RTKs. Guided by cellular and in vivo studies of receptor/ligand
relationships we will study ligand-induced complexes biochemically, and with high-resolution structural
approaches, in order to understand in detail how Wnt protein binding leads to activation of the receptors and
co-receptors in the signaling complex. In pursuing these studies, we will investigate the role played by Wnt
acylation – requirements for which appear to be different for binding to Frizzled-family and RTK-family Wnt
receptors. We also hope to define specificity determinants in the Wnt proteins for distinct modes of signaling.
In parallel with these pursuits, we will use a structurally-guided approach, combined with chemical biology and
functional analysis of mutated receptors, to explore the mechanism of signaling by pseudokinases in the RTK
superfamily. These studies will have important implications for the 10% of the human kinome thought to be
pseudokinases, and will systematically test the hypothesis that regulated switching of pseudokinase
conformation is required for signaling. Our approaches will also bring new opportunities for therapeutic
targeting of pseudokinases such as PTK7, Ror2, and Ror1, which have been implicated in several diseases.
Together, our studies will provide important fundamental new insight into signaling by a class of receptors that
do not fit into normal paradigms for RTKs or Wnt receptors. Understanding them is crucial for deconvoluting
the complexity of Wnt signaling specificity and teasing out its multiple roles. In addition, our findings should
open new avenues for potential therapeutic inhibition – as the roles of these Wnt-binding RTKs in disease
become increasingly clear.
项目摘要
这项MIRA申请中提出的研究旨在了解
跨受体酪氨酸激酶(RTK)超家族的跨膜信号传导,其成员发挥作用,
在人类疾病--从神经发育障碍到骨病、癌症、糖尿病
还有几处先天畸形在RTK信号传导的传统观点中,生长因子配体诱导
受体二聚体成为酪氨酸自磷酸化和招募下游信号分子。正如我们
了解有关20个不同的RTK系列(其中包括58个RTK)的更多信息,但是,它变得更加清晰
这种观点只适用于这些受体的一个子集。本文的研究重点是两个
需要非常不同的机制观点的特征-结合Wnt蛋白(并且不结合Wnt蛋白)的RTK
结果二聚化)和在其胞内区域具有“死”激酶或假激酶的RTK。新
为了理解这些重要的受体如何发出信号,必须理解范例。我们的目标结束了
未来5-10年是:1.为了对RTK在Wnt信号传导中所起的作用形成一个连贯的图景(这
涉及20个RTK系列中的4个),2.为了了解带有假激酶结构域的RTK如何,
结合ATP(在20个RTK家族中的5个中发现)可以信号传导,以及3.为了确定为什么假激酶-
在Wnt监管的RTK中代表。以受体/配体的细胞和体内研究为指导
关系,我们将研究配体诱导的复合物生化,并与高分辨率的结构
方法,以详细了解Wnt蛋白结合如何导致受体的激活,
信号复合物中的辅助受体。在进行这些研究时,我们将研究Wnt在其中所起的作用。
酰化-结合卷曲家族和RTK家族Wnt的要求似乎不同
受体。我们还希望在Wnt蛋白中确定不同信号传导模式的特异性决定簇。
在这些追求的同时,我们将使用结构指导的方法,结合化学生物学和
突变受体的功能分析,以探索RTK中假激酶的信号转导机制
超家族这些研究将对10%的人类激酶组产生重要影响,
假激酶,并将系统地测试假设,调节开关的假激酶
信号传导需要构象。我们的方法也将为治疗带来新的机会。
靶向假激酶,如PTK 7、Ror 2和Ror 1,它们与几种疾病有关。
总之,我们的研究将为一类受体的信号传导提供重要的基础新见解,
不符合RTK或Wnt受体的正常模式。理解它们对于解卷积至关重要
Wnt信号特异性的复杂性,并梳理出它的多重作用。此外,我们的研究结果应该
为潜在的治疗抑制开辟了新的途径-这些Wnt结合RTK在疾病中的作用
变得越来越清晰。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark A Lemmon其他文献
Mark A Lemmon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark A Lemmon', 18)}}的其他基金
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
- 批准号:
10678825 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck
项目 1:改进 EGFR 家族成员在头颈鳞状细胞癌中的靶向作用
- 批准号:
10668978 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
- 批准号:
10263909 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck
项目 1:改进 EGFR 家族成员在头颈鳞状细胞癌中的靶向作用
- 批准号:
10441508 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck
项目 1:改进 EGFR 家族成员在头颈鳞状细胞癌中的靶向作用
- 批准号:
10267847 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
- 批准号:
10400914 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
- 批准号:
9914306 - 财政年份:2017
- 资助金额:
$ 80.4万 - 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
- 批准号:
10598118 - 财政年份:2017
- 资助金额:
$ 80.4万 - 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
- 批准号:
10406442 - 财政年份:2017
- 资助金额:
$ 80.4万 - 项目类别:
Understanding Wnt signaling through Ror and Ryk family receptor tyrosine kinases
了解通过 Ror 和 Ryk 家族受体酪氨酸激酶的 Wnt 信号传导
- 批准号:
9244390 - 财政年份:2016
- 资助金额:
$ 80.4万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 80.4万 - 项目类别:
Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
- 批准号:
MR/X00029X/1 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
- 批准号:
2312378 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
- 批准号:
10680969 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
- 批准号:
23K06597 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
- 批准号:
23K05034 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
- 批准号:
2838427 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Studentship
RNA-binding proteins in bacterial virulence and host-pathogen interactions
RNA结合蛋白在细菌毒力和宿主-病原体相互作用中的作用
- 批准号:
10659346 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别: